ZOSTAVAX™ Safety and Immunogenicity in Korean Adults (V211-034)

Clinical trial NCT01556451 · COMPLETED

Trial details

NCT number: NCT01556451
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Herpes Zoster Shingles

Start date: 2012-04-01
Primary completion: 2012-10-01
Enrollment: 180

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.